BioCardia BCDA Stock
BioCardia Price Chart
BioCardia BCDA Financial and Trading Overview
| BioCardia stock price | 0.87 USD |
| Previous Close | 0.93 USD |
| Open | 0.92 USD |
| Bid | 0.66 USD x 200 |
| Ask | 1.19 USD x 200 |
| Day's Range | 0.91 - 0.99 USD |
| 52 Week Range | 0.84 - 2.45 USD |
| Volume | 64.99K USD |
| Avg. Volume | 162.59K USD |
| Market Cap | 10.46M USD |
| Beta (5Y Monthly) | 0.551 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.85 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 15.5 USD |
BCDA Valuation Measures
| Enterprise Value | 9.93M USD |
| Trailing P/E | N/A |
| Forward P/E | -1.6428572 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | -1.272 |
Trading Information
BioCardia Stock Price History
| Beta (5Y Monthly) | 0.551 |
| 52-Week Change | -57.79% |
| S&P500 52-Week Change | 27.29% |
| 52 Week High | 2.45 USD |
| 52 Week Low | 0.84 USD |
| 50-Day Moving Average | 1.11 USD |
| 200-Day Moving Average | 1.34 USD |
BCDA Share Statistics
| Avg. Volume (3 month) | 162.59K USD |
| Avg. Daily Volume (10-Days) | 116.14K USD |
| Shares Outstanding | 11.37M |
| Float | 8.76M |
| Short Ratio | 0.8 |
| % Held by Insiders | 30.03% |
| % Held by Institutions | 7.12% |
| Shares Short | 245.78K |
| Short % of Float | 2.57% |
| Short % of Shares Outstanding | 2.16% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:15 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2025 |
| Most Recent Quarter (mrq) | March 31, 2026 |
| Next Fiscal Year End | December 31, 2026 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -251.99% |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | -4667000 USD |
| EBITDA | -7803000 USD |
| Net Income Avi to Common (ttm) | -7775000 USD |
| Diluted EPS (ttm) | -0.85 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 951K USD |
| Total Cash Per Share (mrq) | 0.08 USD |
| Total Debt (mrq) | 412K USD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 0.41 |
| Book Value Per Share (mrq) | -0.097 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -7477000 USD |
| Levered Free Cash Flow (ttm) | -4943250 USD |
Profile of BioCardia
| Country | United States |
| State | CA |
| City | Sunnyvale |
| Address | 320 Soquel Way |
| ZIP | 94085 |
| Phone | 650 226 0120 |
| Website | https://www.biocardia.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 17 |
BioCardia, Inc., a clinical-stage regenerative medicine company, develops cellular and cell-derived therapeutics for cardiovascular and pulmonary diseases in the United States. The company's lead product candidate is CardiAMP, an autologous mononuclear cell therapy system in Phase III clinical trial for the treatment of ischemic heart failure with reduced ejection fraction and refractory angina resulting from chronic myocardial ischemia. It also provides CardiALLO, an allogeneic mesenchymal stem cell therapy which is in phase II for ischemic heart failure; allogeneic cell therapy platform; and PulmALLO, an allogeneic mesenchymal stem cell therapy for acute respiratory distress syndrome. In addition, the company offers the Helix biotherapeutic delivery system for minimally invasive targeted delivery of biologic agents to the heart; Heart3D for fusion imaging; and morph DNA and avance steerable introducers. It has a license and distribution agreement with Biomet Biologics, LLC. BioCardia, Inc. is based in Sunnyvale, California.
Q&A For BioCardia Stock
What is a current BCDA stock price?
BioCardia BCDA stock price today per share is 0.87 USD.
How to purchase BioCardia stock?
You can buy BCDA shares on the Tech Market Small exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for BioCardia?
The stock symbol or ticker of BioCardia is BCDA.
Which industry does the BioCardia company belong to?
The BioCardia industry is Biotechnology.
How many shares does BioCardia have in circulation?
The max supply of BioCardia shares is 11.37M.
What is BioCardia Price to Earnings Ratio (PE Ratio)?
BioCardia PE Ratio is now.
What was BioCardia earnings per share over the trailing 12 months (TTM)?
BioCardia EPS is -0.85 USD over the trailing 12 months.
Which sector does the BioCardia company belong to?
The BioCardia sector is Healthcare.
BioCardia BCDA included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| US Tech Composite IXIC | 26853.98 USD — |
-0.89
|
8.32B USD — | 26769.16 USD — | 27130.88 USD — | — - | 8.32B USD — |
| US Tech Capital Market Composite RCMP | 148.96 USD — |
-1.84
|
— — | 148.23 USD — | 151.02 USD — | — - | — — |
| US Tech Health Care IXHC | 1133.51 USD — |
+1.54
|
— — | 1113.35 USD — | 1133.95 USD — | — - | — — |
- {{ link.label }} {{link}}